Skip to nav Skip to content

IDSA Response to FDA and CDC Decision to Expand COVID-19 Vaccine Booster Eligibility

Facebook Twitter LinkedIn Email

IDSA HIVMA Joint Logo Updated.png

 

 

IDSA Response to FDA and CDC Decision to Expand COVID-19 Vaccine Booster Eligibility

 

The Infectious Diseases Society of America supports the FDA and CDC decision to expand eligibility for COVID-19 vaccine boosters to include everyone age 18 and older.

Data show that a booster shot provides highly effective continued protection against breakthrough COVID-19 infections, serious illness, hospitalization and death. Everyone 18 and older who received a two-dose mRNA vaccine should get their booster shots six months after they completed the series to maximize protection against COVID-19.

As cases are rising in some parts of the United States, infectious diseases experts urge everyone who is eligible — including children 5 and older — to get vaccinated. Before you travel or gather with loved ones this holiday season, get vaccinated so you can celebrate safely.

Daniel P. McQuillen, MD, FIDSA – President, Infectious Diseases Society of America

About IDSA
The Infectious Diseases Society of America (IDSA) is a community of over 12,000 physicians, scientists, and public health experts who specialize in infectious diseases. Its purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases. Learn more at https://www.idsociety.org/.

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.